| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.092 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.09 | 0.06 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |